Porton Pharma Solutions Ltd. (300363.SZ)
CNY 17.08
(0.59%)
CNY 17.08
(0.59%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 268.91 Million CNY | -87.49% |
| 2022 | 2.26 Billion CNY | 300.48% |
| 2021 | 565.59 Million CNY | 60.57% |
| 2020 | 352.23 Million CNY | 32.52% |
| 2019 | 265.79 Million CNY | 72.64% |
| 2018 | 153.96 Million CNY | 34.39% |
| 2017 | 114.56 Million CNY | -44.81% |
| 2016 | 207.59 Million CNY | 60.83% |
| 2015 | 129.07 Million CNY | -9.55% |
| 2014 | 142.7 Million CNY | 23.14% |
| 2013 | 115.89 Million CNY | 16.07% |
| 2012 | 99.84 Million CNY | 33.6% |
| 2011 | 74.73 Million CNY | 26.57% |
| 2010 | 59.04 Million CNY | 29.42% |
| 2009 | 45.62 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -116.78 Million CNY | 14.69% |
| 2024 Q3 | -48.78 Million CNY | 58.22% |
| 2024 Q1 | -136.89 Million CNY | 10.72% |
| 2023 Q4 | -153.33 Million CNY | -1311.97% |
| 2023 Q1 | 318.32 Million CNY | -38.28% |
| 2023 Q3 | 12.65 Million CNY | -88.97% |
| 2023 Q2 | 114.74 Million CNY | -63.95% |
| 2023 FY | 283.28 Million CNY | -87.49% |
| 2022 Q2 | 965.92 Million CNY | 128.89% |
| 2022 FY | 2.26 Billion CNY | 300.48% |
| 2022 Q4 | 515.74 Million CNY | 104.75% |
| 2022 Q3 | 251.88 Million CNY | -73.92% |
| 2022 Q1 | 421.99 Million CNY | 139.41% |
| 2021 FY | 565.59 Million CNY | 60.57% |
| 2021 Q1 | 93.33 Million CNY | 8.86% |
| 2021 Q4 | 176.26 Million CNY | 15.67% |
| 2021 Q3 | 152.38 Million CNY | 6.11% |
| 2021 Q2 | 143.6 Million CNY | 53.86% |
| 2020 FY | 352.23 Million CNY | 32.52% |
| 2020 Q4 | 85.73 Million CNY | -33.73% |
| 2020 Q3 | 129.36 Million CNY | 60.52% |
| 2020 Q2 | 80.59 Million CNY | 42.55% |
| 2020 Q1 | 56.53 Million CNY | 62.53% |
| 2019 Q3 | 82.32 Million CNY | 46.86% |
| 2019 Q4 | 34.78 Million CNY | -57.75% |
| 2019 FY | 265.79 Million CNY | 72.64% |
| 2019 Q1 | 21.52 Million CNY | -66.18% |
| 2019 Q2 | 56.05 Million CNY | 160.49% |
| 2018 Q2 | 6.74 Million CNY | -70.08% |
| 2018 FY | 153.96 Million CNY | 34.39% |
| 2018 Q4 | 63.62 Million CNY | 4.22% |
| 2018 Q3 | 61.05 Million CNY | 805.49% |
| 2018 Q1 | 22.53 Million CNY | -32.95% |
| 2017 Q1 | 65.13 Million CNY | 18.21% |
| 2017 FY | 114.56 Million CNY | -44.81% |
| 2017 Q4 | 33.61 Million CNY | 216.02% |
| 2017 Q3 | 10.63 Million CNY | 105.16% |
| 2017 Q2 | 5.18 Million CNY | -92.04% |
| 2016 Q3 | 33.78 Million CNY | -47.01% |
| 2016 Q2 | 63.75 Million CNY | 15.99% |
| 2016 Q4 | 55.1 Million CNY | 63.11% |
| 2016 FY | 207.59 Million CNY | 60.83% |
| 2016 Q1 | 54.96 Million CNY | 71.93% |
| 2015 FY | 129.07 Million CNY | -9.55% |
| 2015 Q4 | 31.96 Million CNY | 2.89% |
| 2015 Q3 | 31.06 Million CNY | 13.22% |
| 2015 Q2 | 27.44 Million CNY | -28.89% |
| 2015 Q1 | 38.59 Million CNY | -40.82% |
| 2014 Q2 | 17.18 Million CNY | -49.96% |
| 2014 Q1 | 34.34 Million CNY | 3540.23% |
| 2014 FY | 142.7 Million CNY | 23.14% |
| 2014 Q4 | 65.21 Million CNY | 151.27% |
| 2014 Q3 | 25.95 Million CNY | 51.01% |
| 2013 Q2 | 18.62 Million CNY | -63.01% |
| 2013 FY | 115.89 Million CNY | 16.07% |
| 2013 Q1 | 50.36 Million CNY | 0.0% |
| 2013 Q3 | 45.95 Million CNY | 146.7% |
| 2013 Q4 | 943.51 Thousand CNY | -97.95% |
| 2012 FY | 99.84 Million CNY | 33.6% |
| 2011 FY | 74.73 Million CNY | 26.57% |
| 2010 FY | 59.04 Million CNY | 29.42% |
| 2009 FY | 45.62 Million CNY | 0.0% |